The South-Eastern Norway Regional Health Authority hereby announces a call for applications for research projects and research activities starting in 2019.
The total funding available for this call is approximately 100 million Norwegian kroner.
Application deadline is Tuesday, September 5th 2018 kl. 16:00.
Published in major journals, first or last author from Oslo University Hospital.
Autoantibodies Against Methylglyoxal-Modified Apolipoprotein B100 and ApoB100 Peptide Are Associated With Less Coronary Artery Atherosclerosis and Retinopathy in Long-Term Type 1 Diabetes
Diabetes Care (in press)
Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction
J Am Coll Cardiol, 77 (15), 1845-1855
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
N Engl J Med (in press)